Corcept Therapeutics (CORT) Operating Margin Growth (1y) (2013 - 2026)

Corcept Therapeutics (CORT) Operating Margin Growth (1y) (2013 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Operating Margin Growth (1y) (Qtr)
1 Oculis Holding AG 66,621.14 Bn 66,620.85 Bn - -
2 Nanobiotix 1,915.18 Bn 1,915.11 Bn - -
3 Akari Therapeutics 1,014.18 Bn 1,014.18 Bn - -
4 BeOne Medicines 471.27 Bn 466.48 Bn 1.35 Bn 1,552.00
5 Vertex Pharmaceuticals 121.81 Bn 114.57 Bn 2.59 Bn 1,536.00
6 Regeneron Pharmaceuticals 69.58 Bn 60.82 Bn 3.31 Bn -170.00
7 Belite Bio 62.72 Bn 62.72 Bn - -
8 Argenx Se 55.51 Bn 50.33 Bn 1.41 Bn 1,049.00
9 Revolution Medicines 37.35 Bn 37.35 Bn - -
10 Corcept Therapeutics 9.56 Bn 9.22 Bn 162.02 Mn -3,225.00

Historic Data

Download Data
DateValue
Mar 31, 2026 -3,225.00
Dec 31, 2025 -1,167.00
Sep 30, 2025 -2,061.00
Jun 30, 2025 -801.00
Mar 31, 2025 -1,792.00
Dec 31, 2024 -950.00
Sep 30, 2024 30.00
Jun 30, 2024 -340.00
Mar 31, 2024 604.00
Dec 31, 2023 156.00
Sep 30, 2023 -617.00
Jun 30, 2023 -527.00
Mar 31, 2023 -1,451.00
Dec 31, 2022 -1,527.00
Sep 30, 2022 -630.00
Jun 30, 2022 -447.00
Mar 31, 2022 385.00
Dec 31, 2021 151.00
Sep 30, 2021 906.00
Jun 30, 2021 -494.00